CAS: 93413-04-8; Asperlicin

该化合物是一个复杂的有机化合物,其特点是多环结构,包括苯并二氮杂卓和quinazoline框架的成分,它具有多个立体器,表明其具有能对其生物活动和药理特性产生重大影响的性能,由于其复杂的结构,它可能与各种生物目标发生相互作用,可能包括受体或酶,因为其结构复杂,该产品可能与不同的生物目标(包括受精器或酶)发生相互作用.诸如氢氧基和碳基母体等功能组的存在表明它可能参与氢结合和其他间分子相互作用.作为苯并氮杂交类的成员,它可能会拥有镇静,无氧或抗convults特性,尽管具体的生物活动需要经验性调查.总体而言,该化合物代表了药物化学和药理学方面的重要领域.

结构式图片

MSDS等安全信息

    上下游产品

    Phenylmethyl 2,3,9,9A-Tetrahydro-9-Hydroxy-2-(2-Methylpropyl)-3-Oxo-9-[(5,6,7,13-Tetrahydro-5,13-Dioxoquinazolino[3,2-A][1,4]Benzodiazepin-7-yl)Methyl]-1H-Imidazo[1,2-A]Indole-1-Carboxylic Acid Ester 102743-51-1
    Benzyl (2S)-4-[[(7S)-5,13-Dioxo-6,7-Dihydroquinazolino[3,2-A][1,4]Benzodiazepin-7-Yl]Methyl]-2-(2-Methylpropyl)-1-Oxo-2H-Imidazo[1,2-A]Indole-3-Carboxylate 210702-49-1
    Benzyl (2S,3Ar,4S)-4-[[(7S,7As)-5,13-Dioxo-6,7,7A,8-Tetrahydroquinazolino[3,2-A][1,4]Benzodiazepin-7-Yl]Methyl]-4-Hydroxy-2-(2-Methylpropyl)-1-Oxo-2,3A-Dihydroimidazo[1,2-A]Indole-3-Carboxylate 210702-50-4
    Benzyl (2S)-4-[[(3S)-1-(2-Azidobenzoyl)-2,5-Dioxo-3,4-Dihydro-1,4-Benzodiazepin-3-Yl]Methyl]-2-(2-Methylpropyl)-1-Oxo-2H-Imidazo[1,2-A]Indole-3-Carboxylate 210702-48-0
    Benzyl (2S)-2-(2-Methylpropyl)-1-Oxo-4-[(2S)-3-Oxo-3-Phenoxy-2-[[2-(2,2,2-Trichloroethoxycarbonylamino)Benzoyl]Amino]Propyl]-2H-Imidazo[1,2-A]Indole-3-Carboxylate 210702-46-8
    Benzyl (2S)-2-(2-Methylpropyl)-1-Oxo-4-[(2S)-3-Oxo-3-Phenoxy-2-(2,2,2-Trichloroethoxycarbonylamino)Propyl]-2H-Imidazo[1,2-A]Indole-3-Carboxylate 210702-45-7
    Phenyl (2S)-3-[1-[(2S)-4-Methyl-2-(Phenylmethoxycarbonylamino)Pentanoyl]Indol-3-Yl]-2-(2,2,2-Trichloroethoxycarbonylamino)Propanoate 210702-44-6

    合成工艺路线路线简述

      📜N-苄氧羰基-L-亮氨酸置于palladium On Activated Charcoal 4-二甲氨基吡啶,Sodium Tetrahydroborate,3-Butyl-1,2-Benzisothiazole-1,1-Dioxide,Tris(Dibenzylideneacetone)Dipalladium (0),三丁基膦,氢气,碘,Mercury(II) Trifluoroacetate,Potassium Carbonate,溶剂黄146,三乙胺,N,N'-二环己基碳二亚胺,三(邻甲基苯基)磷,2,3-二氯-5,6-二氰基-1,4-苯醌,Potassium Iodide,锌体系中,用 甲醇,乙酸乙酯,甲苯,苯 作为反应溶剂,60.0 °C,101.33 Kpa 条件下,反应 48.25H,反应生成 阿斯普尼辛
      参考文献:Total Syntheses Of (−)-Asperlicin And (−)-Asperlicin C
      标题:Total Syntheses Of (−)-Asperlicin And (−)-Asperlicin C
      摘要:
      DOI:10.1021/ja9809408

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1126/science.2994227
      摘要:Chang RS, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schönberg G, Patchett AA, Liesch JM, Hensens OD. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science. 1985 Oct 11;230(4722):177–9. doi: 10.1126/science.2994227.
      参考文献:10.7164/antibiotics.38.1633
      摘要:Goetz MA, Lopez M, Monaghan RL, Chang RS, Lotti VJ, Chen TB. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J Antibiot (Tokyo). 1985 Dec;38(12):1633–7. doi: 10.7164/antibiotics.38.1633.
      参考文献:10.1007/bf02803770
      摘要:Kim KH, Lee MG, Kim DG. The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats. Journal of Gastrointestinal Cancer. 1996 Dec;20(3):205–11. doi: 10.1007/bf02803770.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知